ArticleJournal of neurology2025
Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson's disease, multiple system atrophy, and cerebellar ataxia.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Speech disorders differ between Parkinson's disease (PD) and multiple system atrophy (MSA), but studies focusing on group differences based on syllables or including cerebellar ataxia (CA) are lacking until now. This cross-sectional study aimed to analyze syllable-based speech characteristics in patients with PD, MSA, and CA, as well as healthy controls, to determine their diagnostic utility. Speech samples were collected from 68 PD, 52 MSA, 23 CA, and 70 healthy controls. Participants performed four speech tasks: producing high- and low-pitched sounds for five Korean vowels, repeating 14 Korean consonants with the vowel /a/, raising and lowering pitch of the vowel /a/, and continuously repeating /pa-ta-ka/ for 5 s. Acoustic analysis and artificial intelligence-based exploratory analysis were conducted to identify the syllable combinations that best distinguished between disease groups. Among the four speech tasks, the sequential motion rate task (/pa-ta-ka/ repetition) demonstrated the highest classification accuracy in distinguishing PD, MSA, and CA from the other groups, with accuracies of 68.90%, 77.42%, and 73.39%, respectively. For single syllable sequence, the /ka-ka-ka/ sequence achieved the highest accuracy, distinguishing CA from other groups with an accuracy of 78.92%. Among combined syllable sequence, the /aaa-hahaha/ sequence exhibited accuracies of 78.63% and 83.33% in differentiating PD and CA, respectively, while the /dadada-aaa/ sequence showed an accuracy of 80.24% in distinguishing MSA from other groups. These findings suggest that syllable-based speech characteristics, along with acoustic parameters, can discriminate among parkinsonian disorders and CA, highlighting their potential as a promising diagnostic tool.
Indexed as
Identifiers
40913192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.